4.7 Article

Continuous and long-term treatment is more important than dosage for the protective effect of thiazide use on bone metabolism and fracture risk

期刊

JOURNAL OF INTERNAL MEDICINE
卷 279, 期 1, 页码 110-122

出版社

WILEY
DOI: 10.1111/joim.12397

关键词

bone metabolism; diuretics; fractures; osteoporosis; thiazides

资金

  1. Eli Lilly
  2. Obel Family Foundation
  3. MSD
  4. Servier
  5. Amgen
  6. Novartis
  7. Sanofi-Aventis

向作者/读者索取更多资源

BackgroundData from observational studies have suggested that thiazide diuretics protect against fractures. Few studies have investigated time frames from initiation of treatment to fracture occurrence. ObjectiveTo evaluate the time to spinal, hip, femur, wrist and upper extremity fracture occurrence before and after thiazide exposure. MethodsA matched retrospective cohort study of patient information from national Danish patient databases was conducted. Patients with reimbursed prescriptions for noncompounded thiazide diuretics with potassium supplementation (Anatomical Therapeutic Chemical classification system code C03AB) between 1996 and 2011 were matched with nonexposed control subjects by date of birth and gender. Weekly odds ratios (ORs) of fracture occurrence and total incidence rates (IRs) and incidence rate ratios (IRRs) of fracture risk were calculated for the periods before treatment initiation, weeks 1-42 and weeks 43-780. ResultsA total of 1602141 thiazide exposure periods' (468271 individuals) and 1530233 nonexposure periods' (655399 individuals) were included in the analysis. Thiazide use was associated with factors of increased de novo fracture risk. Weekly adjusted fracture risk between exposure and nonexposure was increased prior to commencing thiazide therapy, further increasing from weeks 1-42weeks and then decreasing gradually from weeks 43-780. There was a decreasing trend in total age-adjusted risk during these periods: IRR [95% confidence interval 1.44 [1.42; 1.47], 1.27 [1.24; 1.29] and 1.14 [1.11; 1.18], respectively. Prescription patterns showed several treatment breaks amongst thiazide users. ConclusionsIt appears that thiazides reduce the background risk of fracture that is increased prior to commencing therapy. Long duration and continuity of thiazide exposure seems to be important to obtain this protective effect on fracture risk, but we have found in this study that this approach is not always used in clinical practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据